Viewing StudyNCT06300411



Ignite Creation Date: 2024-05-06 @ 8:13 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06300411
Status: RECRUITING
Last Update Posted: 2024-06-04
First Post: 2024-03-01

Brief Title: SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
Sponsor: SURGE Therapeutics
Organization: SURGE Therapeutics

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Immunotherapy View
Intraoperative View
Ketorolac View
Open-label View
SRG-514 View
Dose escalation View